You have 9 free searches left this month | for more free features.

MYK-224

Showing 1 - 25 of 72

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Volunteers Trial in Anaheim (MYK-224, Placebo)

Completed
  • Healthy Volunteers
  • MYK-224
  • Placebo
  • Anaheim, California
    Local Institution - 0001
Jan 12, 2023

Cardiomyopathy, Hypertrophic Trial in Bologna, Alicante/alacant (MYK-224)

Not yet recruiting
  • Cardiomyopathy, Hypertrophic
  • MYK-224
  • Bologna, BO, Italy
  • +1 more
Sep 23, 2022

Healthy Participants Trial in Dallas (MYK-224, Itraconazole, Verapamil)

Recruiting
  • Healthy Participants
  • MYK-224
  • +2 more
  • Dallas, Texas
    Labcorp CRU
Jun 9, 2022

Healthy Volunteers Trial (MYK-224)

Not yet recruiting
  • Healthy Volunteers
  • MYK-224
  • (no location specified)
Jan 6, 2023

Heart Failure Trial in Worldwide (BMS-986435, Placebo)

Not yet recruiting
  • Heart Failure
  • Atlanta, Georgia
  • +40 more
Nov 3, 2023

Hypertrophic Cardiomyopathy, Obstructive Hypertrophic Cardiomyopathy, Non-obstructive Hypertrophic Cardiomyopathy Trial in

Active, not recruiting
  • Hypertrophic Cardiomyopathy
  • +2 more
  • Scottsdale, Arizona
  • +68 more
Sep 20, 2022

Hypertrophic Cardiomyopathy Trial in United States (mavacamten)

Active, not recruiting
  • Hypertrophic Cardiomyopathy
  • Scottsdale, Arizona
  • +3 more
Jun 10, 2022

Alzheimer, Dementia Trial in San Francisco (Moving Together)

Active, not recruiting
  • Alzheimer Disease
  • Dementia
  • Moving Together
  • San Francisco, California
    University of California, San Francisco
Feb 1, 2023

Non Small Cell Lung Cancer, Cutaneous Melanoma, Head and Neck Squamous Cell Carcinoma Trial in United States (RTX-224)

Terminated
  • Non Small Cell Lung Cancer
  • +4 more
  • Scottsdale, Arizona
  • +4 more
Dec 7, 2022

Advanced Solid Tumor Trial in Huntersville, Fairfax (PEEL-224)

Recruiting
  • Advanced Solid Tumor
  • Scottsdale, Arizona
  • +5 more
Oct 19, 2022

Hepatocellular Carcinoma Trial (Pembrolizumab)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Pembrolizumab
  • (no location specified)
Dec 15, 2022

Primary Membranous Nephropathy Trial in Australia (Obinutuzumab, Oral prednisolone and cyclophosphamide)

Not yet recruiting
  • Primary Membranous Nephropathy
  • Garran, Australian Capital Territory, Australia
  • +12 more
Nov 1, 2023

CCH With Two Different Injection Techniques in Cellulite With

Enrolling by invitation
  • Cellulite
  • +2 more
    • Coral Gables, Florida
    • +2 more
    Feb 28, 2022

    Gout Tophus Trial (WTX221)

    Not yet recruiting
    • Gout Tophus
    • (no location specified)
    Apr 4, 2023

    Aging, Medication Adherence, Hypertension Trial in Tucson, Champaign (Blood Pressure Technology System M, Blood Pressure

    Recruiting
    • Aging
    • +2 more
    • Blood Pressure Technology System M
    • Blood Pressure Technology System E
    • Tucson, Arizona
    • +1 more
    Jan 26, 2023

    Cardiomyopathy, Hypertrophic Obstructive, Left Ventricular Outflow Tract Obstruction Trial in United States (MYK-461)

    Completed
    • Cardiomyopathy, Hypertrophic Obstructive
    • Left Ventricular Outflow Tract Obstruction
    • Scottsdale, Arizona
    • +6 more
    Jun 3, 2021

    Psoriatic Arthritis Trial in Worldwide (filgotinib)

    Terminated
    • Psoriatic Arthritis
    • Brussels, Belgium
    • +24 more
    Apr 20, 2022

    Obstructive Sleep Apnea Trial in Assiut (adenotonsillectomy, Lifestyle intervention)

    Completed
    • Obstructive Sleep Apnea
    • adenotonsillectomy
    • Lifestyle intervention
    • Assiut, Egypt
      Al-Azhar University
    Jun 13, 2022

    Obstructive Hypertrophic Cardiomyopathy Trial in Worldwide (mavacamten, Placebo)

    Completed
    • Obstructive Hypertrophic Cardiomyopathy
    • Scottsdale, Arizona
    • +70 more
    Sep 7, 2021

    Cannabis Use Disorder, Mild, Cannabis Use Disorder, Moderate, Cannabis Use Disorder, Severe Trial in Charleston (Cognitive

    Recruiting
    • Cannabis Use Disorder, Mild
    • +2 more
    • Cognitive Behavioral Therapy (CBT4CBT)
    • Charleston, South Carolina
      Medical University of South Carolina
    Nov 17, 2021

    Dilated Cardiomyopathy, Heart Failure With Reduced Ejection Fraction Trial in Worldwide (MYK-491, Placebo)

    Completed
    • Dilated Cardiomyopathy
    • Heart Failure With Reduced Ejection Fraction
    • Jacksonville, Florida
    • +16 more
    Nov 2, 2020

    Atopic Dermatitis, Type 1 Hypersensitivity Trial in Australia, Puerto Rico, United States (STMC-103H, Placebo)

    Recruiting
    • Atopic Dermatitis
    • Type 1 Hypersensitivity
    • STMC-103H
    • Placebo
    • Tucson, Arizona
    • +25 more
    Dec 1, 2022

    Active Peripheral Spondyloarthritis (pSpA) Trial (Secukinumab, Placebo)

    Not yet recruiting
    • Active Peripheral Spondyloarthritis (pSpA)
    • Secukinumab
    • Placebo
    • (no location specified)
    Mar 22, 2022

    Rheumatoid Arthritis Trial (MBS2320 5 mg, MBS2320 20 mg, MBS2320 40 mg)

    Not yet recruiting
    • Rheumatoid Arthritis
    • MBS2320 5 mg
    • +3 more
    • (no location specified)
    Jul 12, 2022

    Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

    Active, not recruiting
    • Advanced Solid Tumors
    • +7 more
    • Duarte, California
    • +87 more
    Aug 19, 2022